OVdialogue English Library

What is homologous recombination deficiency (HRD) and why does it matter in ovarian cancer?

In this recorded webinar, part of Ovarian Cancer Canada's Speaker Series, Dr. Janice Kwon, Dr. Basile Tessier-Cloutier, Dr. Melica Brodeur, and Alexandria Tadman break down:

• What HRD is in ovarian cancer
• How HRD testing works
• What your HRD results may mean
• How HRD testing can help guide treatment decisions
• Our advocacy efforts to make HRD testing accessible nationwide 

If you or someone you love is living with ovarian cancer or another gynecologic cancer, this session explains how HRD testing and precision medicine can impact treatment decisions.